BlackRock Capital Allocation Term Trust (NYSE:BCAT – Get Free Report) major shareholder Saba Capital Management, L.P. sold 33,209 shares of the company’s stock in a transaction that occurred on Monday, September 23rd. The stock was sold at an average price of $16.44, for a total value of $545,955.96. Following the completion of the sale, the insider now directly owns 16,185,465 shares of the company’s stock, valued at approximately $266,089,044.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Large shareholders that own at least 10% of a company’s stock are required to disclose their transactions with the SEC.
Saba Capital Management, L.P. also recently made the following trade(s):
- On Wednesday, September 25th, Saba Capital Management, L.P. sold 8,800 shares of BlackRock Capital Allocation Term Trust stock. The stock was sold at an average price of $16.44, for a total value of $144,672.00.
- On Thursday, September 19th, Saba Capital Management, L.P. sold 14,973 shares of BlackRock Capital Allocation Term Trust stock. The stock was sold at an average price of $16.41, for a total value of $245,706.93.
- On Tuesday, September 17th, Saba Capital Management, L.P. sold 15,894 shares of BlackRock Capital Allocation Term Trust stock. The stock was sold at an average price of $16.41, for a total value of $260,820.54.
BlackRock Capital Allocation Term Trust Trading Up 0.1 %
Shares of BCAT stock opened at $16.27 on Friday. BlackRock Capital Allocation Term Trust has a fifty-two week low of $13.67 and a fifty-two week high of $17.18. The stock has a 50 day moving average price of $16.30 and a two-hundred day moving average price of $16.21.
BlackRock Capital Allocation Term Trust Increases Dividend
Institutional Trading of BlackRock Capital Allocation Term Trust
Hedge funds and other institutional investors have recently bought and sold shares of the stock. UBS Group AG lifted its position in BlackRock Capital Allocation Term Trust by 8.2% in the fourth quarter. UBS Group AG now owns 1,543,167 shares of the company’s stock valued at $23,070,000 after purchasing an additional 116,638 shares during the last quarter. Prevail Innovative Wealth Advisors LLC bought a new stake in BlackRock Capital Allocation Term Trust in the second quarter valued at approximately $1,452,000. Stifel Financial Corp lifted its position in BlackRock Capital Allocation Term Trust by 30.3% in the fourth quarter. Stifel Financial Corp now owns 488,792 shares of the company’s stock valued at $7,307,000 after purchasing an additional 113,628 shares during the last quarter. Private Advisor Group LLC bought a new stake in BlackRock Capital Allocation Term Trust in the fourth quarter valued at approximately $177,000. Finally, Oppenheimer & Co. Inc. lifted its position in BlackRock Capital Allocation Term Trust by 18.6% in the first quarter. Oppenheimer & Co. Inc. now owns 29,180 shares of the company’s stock valued at $486,000 after purchasing an additional 4,586 shares during the last quarter. Institutional investors own 36.12% of the company’s stock.
BlackRock Capital Allocation Term Trust Company Profile
–
Further Reading
- Five stocks we like better than BlackRock Capital Allocation Term Trust
- The How and Why of Investing in Gold Stocks
- Rocket Lab Stock Soars: Should Investors Chase the Rally?
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- KB Home Slips After Earnings: What’s Next for Homebuilders?
- How to Start Investing in Real Estate
- Micron Stock Soars as AI Demand Fuels Big Q4 Earnings Beat
Receive News & Ratings for BlackRock Capital Allocation Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Capital Allocation Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.